On Friday 05/16/2025 the closing price of the Oscar Health Inc Registered Shs -A- share was $16.56 on BTT.
Compared to the opening price on Friday 05/16/2025 on BTT of $16.56, this is a drop of 0.00%.
Oscar Health Inc Registered Shs -A-'s market capitalization is $3.74 B by 219.16 M shares outstanding.
Is Oscar Health stock a Buy, Sell or Hold?
Oscar Health stock has received a consensus rating of buy. The average rating score is and is based on 11 buy ratings, 8 hold ratings, and 0 sell ratings.What was the 52-week low for Oscar Health stock?
The low in the last 52 weeks of Oscar Health stock was 11.21. According to the current price, Oscar Health is 156.33% away from the 52-week low.What was the 52-week high for Oscar Health stock?
The high in the last 52 weeks of Oscar Health stock was 23.79. According to the current price, Oscar Health is 73.67% away from the 52-week high.What are analysts forecasts for Oscar Health stock?
The 19 analysts offering price forecasts for Oscar Health have a median target of 17.17, with a high estimate of 28.00 and a low estimate of 5.00. The median estimate represents a 102.06 difference from the last price of 17.53.Oscar Health A Stock Snapshot
17.39
Bid
6.00
Bid Size
18.09
Ask
100.00
Ask Size
5/16/2025
Date
3:59 PM
Time
305,492.00
Volume
16.56
Prev. Close
16.56
Open
4.46 B
Market Cap in USD
219.16 M
Number of Shares
254.68 M
Total Number of Shares
16.43
Day Low
17.67
Day High
17.53
11.21
52 Week Low
23.79
52 Week High
17.53
0.00
Dividend in USD
0.00
Dividend Yield
140.44
P/E Ratio
81.86
Free Float in %
0.10
EPS in USD
4.05
Book Value per Share in USD
3.68
Cash Flow per Share in USD
Oscar Health News More News
Historical Prices for Oscar Health
| Date | Open | Close | Daily High | Daily Low |
|---|
Price change over selected period:
0%
0
Oscar Health Analyst Data
Total Analysts: 20
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price
*Price Target
Lowest: 5.00
Median: 16.74
Highest: 28.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.
Oscar Health Analyst Opinions
- All
- Buy
- Hold
- Sell
| Date | Analyst | Rating | Price | |||
|---|---|---|---|---|---|---|
| 03/13/25 | Wells Fargo & Co | Downgraded to Hold | $16 | |||
| 07/10/24 | Piper Sandler | Maintained Buy | $25 | |||
| 06/26/24 | Piper Sandler | Maintained Buy | $25 | |||
| 06/12/24 | Wells Fargo & Co | Maintained Buy | $27 | |||
| 05/30/24 | Bank of America Merrill Lynch | Downgraded to Hold | $21 | |||
| 05/30/24 | Baird Patrick & Co | Maintained Buy | $28 | |||
| 05/20/24 | Bank of America Merrill Lynch | Maintained Buy | $25 | |||
| 05/09/24 | Wells Fargo & Co | Maintained Buy | $24 | |||
| 05/09/24 | Goldman Sachs | Maintained Hold | $21 | |||
| 03/22/24 | Raymond James Financial, Inc. | Maintained Buy | $20 | |||
| 02/15/24 | Wells Fargo & Co | Maintained Buy | $20 | |||
| 02/09/24 | Goldman Sachs | Maintained Hold | $16 | |||
| 11/02/23 | Bank of America Merrill Lynch | Upgraded to Buy | $9 | |||
| 08/30/23 | Morgan Stanley | Maintained Hold | $7.5 | |||
| 08/10/23 | Goldman Sachs | Maintained Hold | $7.5 | |||
| 08/09/23 | Credit Suisse | Maintained Buy | $8.5 | |||
| 07/14/23 | Morgan Stanley | Maintained Hold | $5 | |||
| 06/13/23 | Wells Fargo & Co | Maintained Buy | $12 | |||
| 06/06/23 | Bank of America Merrill Lynch | Upgraded to Hold | $8.75 |
Oscar Health Estimates* in USD
| 2025 | 2026 | 2027 | |
|---|---|---|---|
| Revenue | 11,302 | 10,954 | 13,399 |
| Dividend | 0.00 | 0.00 | 0.00 |
| Dividend Yield (in %) | 0.00 % | 0.00 % | 0.00 % |
| EPS | 0.74 | 0.99 | 1.89 |
| P/E Ratio | 23.76 | 17.67 | 9.27 |
| EBIT | 294 | 379 | 685 |
| EBITDA | 384 | 470 | 781 |
| Net Profit | 229 | 319 | 558 |
| Net Profit Adjusted | 213 | 259 | 590 |
| Pre-Tax Profit | 241 | 355 | 653 |
| Pre-Tax Profit Reported | - | - | - |
| EPS (Non-GAAP) ex. SOE | - | - | - |
| EPS (GAAP) | 0.65 | 0.79 | 2.00 |
| Gross Income | 2,317 | 2,629 | 3,181 |
| Cash Flow from Investing | -125 | -74 | -182 |
| Cash Flow from Operations | 554 | 762 | 1,181 |
| Cash Flow from Financing | 0 | 0 | 0 |
| Cash Flow per Share | 4.41 | 3.80 | 2.02 |
| Free Cash Flow | 583 | 619 | 1,002 |
| Free Cash Flow per Share | - | - | - |
| Book Value per Share | 5.68 | 7.41 | 9.96 |
| Net Debt | -2,623 | -3,017 | -4,441 |
| Research & Development Exp. | - | - | - |
| Capital Expenditure | 28 | 27 | 29 |
| Selling, General & Admin. Exp. | 1,972 | 1,964 | 2,118 |
| Shareholder’s Equity | 1,409 | 1,980 | 2,931 |
| Total Assets | 5,414 | 6,166 | 7,385 |
|
Previous Quarter ending 03/31/25 |
Current Quarter ending 06/30/25 |
Next Quarter ending 09/30/25 |
Current Year ending 12/31/25 |
Next Year ending 12/31/26 |
|
|---|---|---|---|---|---|
| Earnings Estimates | |||||
| No. of Analysts | - | 7 | 8 | 8 | 8 |
| Average Estimate | - | 0.329 USD | -0.110 USD | 0.748 USD | 0.962 USD |
| Year Ago | - | 0.236 USD | -0.225 USD | 0.106 USD | - |
| Publish Date | - | 8/7/2025 | 11/11/2025 | - | - |
| Revenue Estimates | |||||
| No. of Analysts | - | 8 | 8 | 8 | 8 |
| Average Estimate | - | 2,836 USD | 2,785 USD | 11,272 USD | 10,946 USD |
| Year Ago | - | 2,219 USD | 2,423 USD | 9,178 USD | - |
| Publish Date | - | 8/7/2025 | 11/11/2025 | - | - |
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet
Income Statements in Mio. USD
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Sales | 9,177.56 | 5,862.87 | 3,963.64 | 1,838.72 | 462.80 | 488.19 |
| Change of sales in % | 56.54 | 47.92 | 115.57 | 297.30 | -5.20 | - |
| Gross profit on sales | - | - | - | - | - | - |
| Gross profit on sales change in % | - | - | - | - | - | - |
| Operating income | 57.27 | -235.62 | -589.87 | -544.48 | -402.27 | -259.39 |
| Operating income change in % | - | 60.06 | -8.34 | -35.35 | -55.08 | - |
| Income before tax | 33.43 | -267.30 | -610.08 | -570.58 | -405.78 | -259.39 |
| Income before tax change in % | - | 56.19 | -6.92 | -40.61 | -56.44 | - |
| Income after tax | 25.43 | -270.73 | -606.28 | -572.61 | -406.83 | -261.18 |
| Income after tax change in % | - | 55.35 | -5.88 | -40.75 | -55.76 | - |
Balance Sheet in Mio. USD
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Total liabilities | 3,532.53 | 2,554.17 | 2,741.31 | 1,501.25 | 1,246.60 | 485.92 |
| Long-term liabilities per share | - | - | - | - | - | - |
| Equity | 1,016.43 | 806.12 | 892.40 | 1,392.52 | 449.02 | 350.61 |
| Equity change in % | 26.07 | -9.71 | -35.82 | - | -37.11 | - |
| Balance sheet total | 4,548.96 | 3,360.29 | 3,633.71 | 2,893.77 | 1,695.62 | 836.53 |
| Balance sheet total change in % | 35.37 | -7.52 | 25.57 | 70.66 | 102.70 | - |
Key Data in USD
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Sales per share | 34.52 | 26.45 | 18.65 | 10.27 | 1.93 | 2.04 |
| P/E ratio (year end quote, basic EPS) | 140.44 | - | - | - | - | - |
| P/E ratio (year end quote, diluted EPS) | 140.44 | - | - | - | - | - |
| Dividend yield in % | 0.00 | 0.00 | 0.00 | 0.00 | - | - |
| Equity ratio in % | 22.34 | 23.99 | 24.56 | 48.12 | 26.48 | 41.91 |
| Debt ratio in % | 77.66 | 76.01 | 75.44 | 51.88 | 73.52 | 58.09 |
Oscar Health Insider Activity
| Name | Date | shares traded | shares held | Price | type (sell/buy) | option |
|---|---|---|---|---|---|---|
| Robinson Elbert O. Jr. | 05/11/2025 | 25,000.00 | 64,512.00 | 16.43 | Sell | No |
| Bertolini Mark T | 04/02/2025 | 955,556.00 | 2,866,666.00 | n/a | Buy | No |
| Schlosser Mario | 03/04/2025 | 172,269.00 | 375,966.00 | n/a | Buy | No |
| Baltrus Victoria | 03/04/2025 | 10,611.00 | 220,130.00 | n/a | Buy | No |
| Blackley Richard Scott | 03/04/2025 | 103,426.00 | 1,432,520.00 | n/a | Buy | No |
| Liang Janet | 03/04/2025 | 96,962.00 | 194,364.00 | n/a | Buy | No |
| McAnaney Adam | 03/04/2025 | 61,409.00 | 184,785.00 | n/a | Buy | No |
| Liang Janet | 02/23/2025 | 97,402.00 | 97,402.00 | n/a | Buy | No |
| Sankaran Sid | 02/06/2025 | 295,687.00 | n/a | n/a | Sell | No |
| Sankaran Sid | 02/06/2025 | 295,687.00 | 795,686.00 | n/a | Buy | No |
| Quane Alessandrea C. | 12/05/2024 | 6,408.00 | 430,216.00 | 16.52 | Sell | No |
| Quane Alessandrea C. | 12/05/2024 | 10,385.00 | 436,624.00 | 15.93 | Sell | No |
| Blackley Richard Scott | 12/05/2024 | 11,423.00 | 914,402.00 | 16.52 | Sell | No |
| Blackley Richard Scott | 12/05/2024 | 18,516.00 | 925,825.00 | 15.93 | Sell | No |
| Quane Alessandrea C. | 12/04/2024 | 31,250.00 | 447,009.00 | n/a | Buy | No |
| Blackley Richard Scott | 12/04/2024 | 62,500.00 | 944,341.00 | n/a | Buy | No |
| Quane Alessandrea C. | 12/01/2024 | 26,411.00 | 416,243.00 | 18.07 | Sell | No |
| Baltrus Victoria | 12/01/2024 | 7,933.00 | 146,181.00 | 18.07 | Sell | No |
| Baltrus Victoria | 12/01/2024 | 145.00 | 146,036.00 | 18.48 | Sell | No |
| Quane Alessandrea C. | 12/01/2024 | 484.00 | 415,759.00 | 18.48 | Sell | No |
| Bopitiya Ranmali | 12/01/2024 | 18,812.00 | 241,833.00 | 18.07 | Sell | No |
| Bopitiya Ranmali | 12/01/2024 | 345.00 | 241,488.00 | 18.48 | Sell | No |
| Schlosser Mario | 12/01/2024 | 6,399.00 | 82,079.00 | 18.07 | Sell | No |
| Blackley Richard Scott | 12/01/2024 | 456.00 | 881,841.00 | 18.48 | Sell | No |
| Blackley Richard Scott | 12/01/2024 | 24,823.00 | 882,297.00 | 18.07 | Sell | No |
Oscar Health A Dividend Calendar
| Date | Name | Dividend | *yield | Currency |
|---|---|---|---|---|
| 2024 | Oscar Health Inc Registered Shs -A- | 0.00 | 0.00 | USD |
| 2023 | Oscar Health Inc Registered Shs -A- | 0.00 | 0.00 | USD |
| 2022 | Oscar Health Inc Registered Shs -A- | 0.00 | 0.00 | USD |
| 2021 | Oscar Health Inc Registered Shs -A- | 0.00 | 0.00 | USD |
| 2020 | Oscar Health Inc Registered Shs -A- | - | - | USD |
| 2019 | Oscar Health Inc Registered Shs -A- | - | - | USD |
*Yield of the Respective Date
Oscar Health A Calendar
| Event | Estimate | Info | Date |
|---|---|---|---|
| Annual General Meeting | 0.096 USD | Annual General Meeting | 06/04/2025 |
| Earnings Report | 0.310 USD | Q2 2025 Earnings Release | 08/07/2025 |
| Earnings Report | -0.101 USD | Q3 2025 Earnings Release | 11/11/2025 |
| Earnings Report | -0.521 USD | Q4 2025 Earnings Release | 02/05/2026 |
| Earnings Report | 0.762 USD | Q1 2026 Earnings Release | 05/12/2026 |
Oscar Health A Past Events
| Event | Actual EPS | Info | Date |
|---|---|---|---|
| Earnings Report | 0.918 USD | Q1 2025 Earnings Release | 05/07/2025 |
| Earnings Report | -0.619 USD | Q4 2024 Earnings Release | 02/04/2025 |
| Earnings Report | -0.225 USD | Q3 2024 Earnings Release | 11/07/2024 |
| Earnings Report | 0.204 USD | Q2 2024 Earnings Release | 08/07/2024 |
| Annual General Meeting | -1.221 USD | Annual General Meeting | 06/06/2024 |
| Earnings Report | 0.623 USD | Q1 2024 Earnings Release | 05/07/2024 |
| Earnings Report | -0.661 USD | Q4 2023 Earnings Release | 02/07/2024 |
| Earnings Report | -0.293 USD | Q3 2023 Earnings Release | 11/07/2023 |
| Earnings Report | -0.071 USD | Q2 2023 Earnings Release | 08/08/2023 |
| Annual General Meeting | -2.853 USD | Annual General Meeting | 06/08/2023 |
| Earnings Report | -0.183 USD | Q1 2023 Earnings Release | 05/09/2023 |
| Earnings Report | -1.050 USD | Q4 2022 Earnings Release | 02/09/2023 |
| Earnings Report | -0.906 USD | Q3 2022 Earnings Release | 11/08/2022 |
| Earnings Report | -0.531 USD | Q2 2022 Earnings Release | 08/11/2022 |
| Annual General Meeting | -3.200 USD | Annual General Meeting | 06/09/2022 |
| Earnings Report | -0.357 USD | Q1 2022 Earnings Release | 05/10/2022 |
| Earnings Report | -0.948 USD | Q4 2021 Earnings Release | 02/10/2022 |
Oscar Health Profile
Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.